Director Pharmacovigilance Drug Safety

• Developing and maintaining an expert understanding of the safety profile of the assigned products as well as understanding of the relevant strategic context (e.g disease under study safety profile of competitors mechanism of action).
• Safety lead for safety surveillance activities and accountable for the ongoing signal detection evaluation and periodic review of emerging safety data (e.g AEs SAEs Labs) assess for safety trends and timely presentation of important/urgent safety issues together with risk communication/management strategy to the Drug Safety Committee (DSC) company senior management and external stakeholders (e.g Independent Data Safety Monitoring Boards).
• Provide medical evaluation of Individual Case Safety Reports (ICSRs) alongside the study Medical Director/Clinical Science Specialist for assigned products.
• Contribute to the planned BLA/MAA activities and act as subject matter expert for safety related content.
• In collaboration with internal stakeholders and external vendors direct the development preparation and compliance of periodic and annual safety reports (e.g. DSUR) & investigator communications as necessary.
• Respond to safety questions from regulatory authorities as well as regulatory agency audits and inspections and corrective action plans.
• Lead clinical safety and benefit risk sections of regulatory documents and preparation for meetings with regulatory and public health authorities and advisory committees.
• Lead and contribute to the development of the Risk Management Plan.
• Act as the safety representative on crossfunctional development teams including study teams.
• Provide safety related training to company employees as is required.
  
  

• Qualified Physician (GMC or GMC permissible).

• Foundational training and experience in clinical practice with a general medicine background
• Solid experience (a minimum of 23 years) in clinical safety and pharmacovigilance and specifically in phase III trial activity.
• Expertise in preparing clinical safety assessments and regulatory reports/ submissions involving safety information.
• Demonstratable and direct experience of safety data presentation in Marketing authorization and Biologics license applications
• Prior therapeutic experience in dermatology rheumatology immunology or GI would be an advantage.

• Possessing a strong knowledge of international pharmacovigilance requirements specifically in the UK Europe and US and prior experience of regulatory authority interactions.
• Good project management and time management skills required
• Strong knowledge of global regulatory requirements for safety reporting and labeling
• Demonstrated ability to independently evaluate interpret and present complex clinical data
• Demonstrated ability to work within a multidisciplinary team of peers and outside experts
• Good organizational and planning talent with excellent communication skills (written or spoken).

• 2 days a week in our brand new Cambridge office.

MoonLake Immunotherapeuticsis a clinicalstage biopharmaceutical company unlocking the potential of sonelokimab a novel investigational Nanobody for the treatment of the inflammatory disease to revolutionize outcomes for patients.

We continue to make significant progress in our Global Clinical Development Programs. The companys focus is on inflammatory diseases with a major unmet need including hidradenitis suppurativa and psoriatic arthritis conditions affecting millions of people worldwide with a large need for improved treatment options. MoonLake was founded in 2021 and is headquarted in Zug with hubs in Cambridge & Porto.

Further information is available at